Combined Treatment with Oral metronidazole and N-acetylcysteine is Effective in Ethylmalonic Encephalopathy

3547's picture
Journal Title, Volume, Page: 
Nature Medicine 16, 869–871, (2010), doi:10.1038/nm.2188
Year of Publication: 
2010
Authors: 
Carlo Viscomi
The Foundation Carlo Besta Institute of Neurology, Milan, Italy
Alberto B Burlina
The Foundation Carlo Besta Institute of Neurology, Milan, Italy
Imad Dweikat
The Foundation Carlo Besta Institute of Neurology, Milan, Italy
Current Affiliation: 
Department of Medicine, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestin
Mario Savoiardo
The Foundation Carlo Besta Institute of Neurology, Milan, Italy
Costanza Lamperti
The Foundation Carlo Besta Institute of Neurology, Milan, Italy
Tatjana Hildebrandt
The Foundation Carlo Besta Institute of Neurology, Milan, Italy
Valeria Tiranti
Massimo Zeviani
The Foundation Carlo Besta Institute of Neurology, Milan, Italy
Preferred Abstract (Original): 

Ethylmalonic encephalopathy is caused by mutations in ETHE1, a mitochondrial matrix sulfur dioxygenase, leading to failure to detoxify sulfide, a product of intestinal anaerobes and, in trace amounts, tissues. Metronidazole, a bactericide, or N-acetylcysteine, a precursor of sulfide-buffering glutathione, substantially prolonged the lifespan of Ethe1-deficient mice, with the combined treatment being additive. The same dual treatment caused marked clinical improvement in five affected children, with hardly any adverse or side effects.

AttachmentSize
Combined_treatment_with_oral_metronidazole_and_N-acetylcysteine_is_effective_in_ethylmalonic_encephalopathy.pdf374.33 KB